Clinical Trials Directory

Trials / Completed

CompletedNCT03086707

Prefatory Study to Explore Changes in Nasal Mucociliary Clearance and to Standardize Nasal Scraping Procedure

A Two-arm, Open Label, Prefatory Study to Explore Changes in Nasal Mucociliary Clearance Between Smokers and Never Smokers and to Standardize Nasal Scraping Procedure

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
14 (actual)
Sponsor
Philip Morris Products S.A. · Industry
Sex
Male
Age
25 Years – 45 Years
Healthy volunteers
Accepted

Summary

This study intends to evaluate the nasal mucociliary clearance (NMC) by determining the value obtained for saccharin transit time (STT) test over the course of 12 hours following a single cigarette use in adult smokers, to compare it relative to never smokers, and to examine the relationship between plasma nicotine levels and STT value in smokers and never smokers. Safety will also be monitored during the study. The planned maximum study duration for a single study participant from Screening through completion of study will be 33 days.

Conditions

Interventions

TypeNameDescription
OTHERCigaretteAfter enrollment, and between Visit 2 and Visit 3, the subjects will abstain from smoking for a period of 8 hours. At Visit 3, after the 8-hour smoking abstinence period, the subjects will smoke 1 single cigarette.

Timeline

Start date
2017-01-21
Primary completion
2017-08-14
Completion
2017-09-29
First posted
2017-03-22
Last updated
2020-11-20
Results posted
2020-10-23

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03086707. Inclusion in this directory is not an endorsement.

Prefatory Study to Explore Changes in Nasal Mucociliary Clearance and to Standardize Nasal Scraping Procedure (NCT03086707) · Clinical Trials Directory